ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIRO..CY..TRBGCZEEHUPLSK....IS..............................*JBDM Ver 0.1.63 (23 May 2017) - 2999001/01969127CORRECTED NEW EUROPEAN PATENT SPECIFICATIONB8B220171213W173deBibliographieenBibliographyfrBibliographieEP06848864.220061221200807182009022320170712enenen752642 P20051221US201712132017502008091720083820140618201425201401082017071220172820171213201750C12N 15/57 20060101AFI20070824BHEP C12P 21/02 20060101ALI20070824BHEP deVERFAHREN ZUR HERSTELLUNG BIOLOGISCH WIRKSAMER VITAMIN-K-ABHÄNGIGER PROTEINE MIT REKOMBINANTEN VERFAHRENenMETHOD OF PRODUCING BIOLOGICALLY ACTIVE VITAMIN K DEPENDENT PROTEINS BY RECOMBINANT METHODSfrPROCÉDÉ DE PRODUCTION DE PROTÉINES DÉPENDANTES DE LA VITAMINE K BIOLOGIQUEMENT ACTIVES PAR DES PROCÉDÉS RECOMBINANTSEP-A2- 2 385 125WO-A-02/29045WO-A-92/01795WO-A-92/09698WO-A-92/19636WO-A-96/34966WO-A-2005/030039WO-A-2005/038019WO-A-2006/067116WO-A-2006/089613WO-A-2006/101474WO-A-2006/110083WO-A2-2005/030039US-A- 5 888 809US-A- 5 888 809US-A1- 2006 121 574WAJIH N ET AL: "Increased production of functional recombinant human clotting factor IX by baby hamster kidney cells engineered to overexpress VKORC1, the vitamin K 2,3-epoxide-reducing enzyme of the vitamin K cycle" JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOCHEMICAL BIOLOGISTS, BIRMINGHAM,, US, vol. 280, no. 36, 19 July 2005 (2005-07-19), pages 31603-31607, XP002375182 ISSN: 0021-9258SUN YAN-MEI ET AL: "Vitamin K epoxide reductase significantly improves carboxylation in a cell line overexpressing factor X" BLOOD, W.B.SAUNDERS COMPANY, ORLANDO, FL, US, vol. 106, no. 12, 4 August 2005 (2005-08-04), pages 3811-3815, XP002377556 ISSN: 0006-4971WASLEY L C ET AL: "PACE/FURIN CAN PROCESS THE VITAMIN K-DEPENDENT PRO-FACTOR IX PRECURSOR WITHIN THE SECRETORY PATHWAY" JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOCHEMICAL BIOLOGISTS, BIRMINGHAM,, US, vol. 268, no. 12, 25 April 1993 (1993-04-25), pages 8458-8465, XP001094106 ISSN: 0021-9258REHEMTULLA A ET AL: "In vitro and in vivo functional characterization of bovine vitamin K-dependent gamma-carboxylase expressed in Chinese hamster ovary cells" PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE, WASHINGTON, DC, US, vol. 90, no. 10, May 1993 (1993-05), pages 4611-4615, XP002204115 ISSN: 0027-8424WAJIH NADEEM ET AL: "Engineering of a recombinant vitamin K-dependent gamma-carboxylation system with enhanced gamma-carboxyglutamic acid forming capacity - Evidence for a functional CXXC redox center in the system" JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOCHEMICAL BIOLOGISTS, BIRMINGHAM,, US, vol. 280, no. 11, 7 January 2005 (2005-01-07), pages 10540-10547, XP002377554 ISSN: 0021-9258ROTH DAVID A ET AL: "Human recombinant factor IX: Safety and efficacy studies in hemophilia B patients previously treated with plasma-derived factor IX concentrates" BLOOD, vol. 98, no. 13, 15 December 2001 (2001-12-15), pages 3600-3606, XP002442457 ISSN: 0006-4971RUNNING DEER JENNIFER ET AL: "High-level expression of proteins in mammalian cells using transcription regulatory sequences from the Chinese hamster EF-1alpha gene", BIOTECHNOLOGY PROGRESS, AMERICAN INSTITUTE OF CHEMICAL ENGINEERS, US, vol. 20, no. 3, 10 March 2004 (2004-03-10) , pages 880-889, XP002557337, ISSN: 8756-7938, DOI: 10.1021/BP034383R [retrieved on 2008-09-05]KAUFMAN R J ET AL: "EXPRESSION PURIFICATION AND CHARACTERIZATION OF RECOMBINANT GAMMA CARBOXYLATED FACTOR-IX SYNTHESIZED IN CHINESE HAMSTER OVARY CELLS", JOURNAL OF BIOLOGICAL CHEMISTRY.(MICROFILMS), AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, US, vol. 261, no. 21, 25 July 1986 (1986-07-25), pages 9622-9628, XP002375183,TERUYA K. ET AL: 'An approach to further enhance the cellular productivity of exogenous protein hyper-producing Chinese hamster ovary (CHO) cells' CYTOTECHNOLOGY vol. 47, 2005, pages 29 - 36WAJIH N. ET AL: 'The inhibitory effect of calumenin on the vitamin K-dependent y-carboxylation stistem' THE JOURNAL OF BIOLOGICAL CHEMISTRY vol. 279, no. 24, 2004, pages 25276 - 25283WALSH G. ET AL: 'Post-translational modifications in the context of therapeutic proteins' NATURE BIOTECHNOLOGY vol. 24, no. 10, October 2006, pages 1241 - 1252RUNNING DEERE J. ET AL: 'High-level expression of proteins in mammalian cells using transcription regulatory sequences from the Chinese hamster EF-1a gene' BIOTECHNOL. PROG. vol. 20, 2004, pages 880 - 889GGCX (P38435), Molecular Target Synopsis, downloaded Feb. 25, 2015NAKAI H. ET AL: 'Adeno-associated viral vector-mediated gene transfer of human blood coagulation factor IX into mouse liver' BLOOD vol. 91, no. 12, 15 June 1998, pages 4600 - 4607KAUFMAN R.J. ET AL: 'Expression, purification, and characterization of recombinant y-carboxylated factor IX synthesized in Chinese hamster ovary cells' THE JOURNAL OF BIOLOGICAL CHEMISTRY vol. 261, no. 21, 1986, pages 9622 - 9628CLS Behring/Coagulation Factor IX (Human) Mononine®Mononine 1000 IU (https://www.medicines.org.uk/emc/medicine/ 14372), downloaded on March 17, 201511157194.9238512520110307DROHAN, William, N.8300 Botsford Ct.Springfield, VA 22152USGRIFFITH, Michael, J.28761 Via Buena VistaSan Juan Capistrano, California 92675USTAYLOR, John, R.45 E. 89th Street, Apt. 40ENew York, New York 10128USSTAFFORD, Darrel, W.300 Rainbow DriveCarrboro, North Carolina 27599USAptevo BioTherapeutics LLC101694824PT066EP2401 4th Avenue, Suite 1050Seattle WA 98121USUniversity of North Carolina at Chapel Hill101061943PT066EPChapel Hill, NC 27599USGill Jennings & Every LLP101574570The Broadgate Tower 20 Primrose StreetLondon EC2A 2ESGB01201503181Baxter International Inc.101296992One Baxter ParkwayDeerfield, IL 60015USHoffmann Eitle100061036Patent- und Rechtsanwälte PartmbB Arabellastraße 3081925 MünchenDEATBEBGCHCYCZDEDKEEESFIFRGBGRHUIEISITLILTLULVMCNLPLPTROSESISKTRUS200604895420061221enWO200707597620070705200727